SCHEMBL1930862

SCHEMBL1930862

CCC(Cc1ccc(Cl)c(N)c1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.48
EPHX2 P34913 1/20 0.48
PPARA Q07869 6/20 0.46
PLA2G10 O15496 1/20 0.44
PLA2G2A P14555 1/20 0.44
CYP1A2 P05177 2/20 0.43
LMNA P02545 2/20 0.43
CHRM1 P11229 1/20 0.43
TBXA2R P21731 1/20 0.43
PDE4A P27815 1/20 0.43
ADRA1A P35348 1/20 0.43
CYP2C9 P11712 1/20 0.43
HIF1A Q16665 1/20 0.43
KDM4E B2RXH2 1/20 0.43
PPARD Q03181 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
KMO O15229 1/20 0.42
CPB2 Q96IY4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15709546 1.00 PPARG (0.48) PPARGEPHX2PPARAPLA2G10PLA2G2A
SCHEMBL15709565 1.00 PPARG (0.48) PPARGEPHX2PPARAPLA2G10PLA2G2A
SCHEMBL1932747 0.86 PPARG (0.51) PPARGPPARALMNAPPARDSMN1; SMN2
SCHEMBL1931035 0.86 PPARG (0.51) PPARGPPARALMNAPPARDSMN1; SMN2
SCHEMBL1906000 0.85 EPHX2 (0.54) PPARGEPHX2PPARASMN1; SMN2CPB2
SCHEMBL6901178 0.85 EPHX2 (0.54) PPARGEPHX2PPARASMN1; SMN2CPB2
SCHEMBL1903633 0.85 EPHX2 (0.54) PPARGEPHX2PPARASMN1; SMN2CPB2
SCHEMBL27668100 0.82 EPHX2 (0.48) PPARGEPHX2PPARAPLA2G10PLA2G2A
SCHEMBL15709525 0.81 KDM4E (0.49) PPARAPLA2G10PLA2G2ALMNAKDM4E
SCHEMBL15709469 0.81 KDM4E (0.49) PPARAPLA2G10PLA2G2ALMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9018414-B2 Substituted 3-phenylpropionic acids and the use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-04-28 US disclosed
US-20140142069-A1 SUBSTITUTED 3-PHENYLPROPIONIC ACIDS AND THE USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-05-22 US disclosed
US-20110130445-A1 SUBSTITUTED 3-PHENYLPROPIONIC ACIDS AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140142069-A1 SUBSTITUTED 3-PHENYLPROPIONIC ACIDS AND THE USE THEREOF FABP3, PC, PAH PPARG 15/4885EPHX2 2324/4885PPARA 5/4885
US-20110130445-A1 SUBSTITUTED 3-PHENYLPROPIONIC ACIDS AND THE USE THEREOF FABP3, PC, PAH PPARG 15/4885EPHX2 2324/4885PPARA 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.